ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Lombardi Cancer Center, UDC Collaborate to Increase Cancer Awareness Among Blacks

August 3, 2001

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991

New ACS Program Honors Mary Lasker

August 31, 1984

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010